Summary A comparison of the ELISA test with the newly-developed MLPA test was carried out, using eluates of blood spots from filter paper for the detection of the anti-PGL-I antibody. A very good positive correlation was observed between these two tests. The concordance rate was fo und to be 92,6%, ranging from 71-4% to 100%. This nonconcordance was not fo und when freshly-collected samples were used. The MLPA test is simple and reliable. The use of eluates from blood spots collected on filter paper fu rther simplifies the test in the collection and transportation of blood samples. This accurate and rapid method makes the MLPA test logistically fe asible for large-scale screening. With our modification of MLPA with eluates more samples can be screened with the kit than with sera.
COLLECTION OF BLOOD SAMPLES
Blood samples were collected by venepuncture and finger prick. In the latter method blood oozing out of the finger tip cut by a lancet was absorbed on a strip of Whatman chromatography filter paper, No. 3 (2·0 x 7·5 cm). About 50 J.ll of blood was collected by this method. After air-drying, the filter paper strips and sera were placed in plastic self sealing bags, and the samples were kept at -20°C until further use.
ELUTION OF BLOOD SPOTS
Two small discs of 7 -mm diameter were cut from the dried blood spots on filter paper and eluted in 225 III of phosphate-buffered saline (pH 7·2) with 0·05% Tween-20 (PBST) containing 1 % bovine serum albumin (BSA). The elution was carried out at room temperature for I hour, which gave a serum dilution of I : 20.
ELISA
ELISA was done using the same procedure as reported earlier. I I Briefly ND-O-BSA antigen supplied by IMMLEPjWHO was diluted in carbonate bicarbonate buffer (CBCB) pH 9·6 and 50 III per well was added to half of a 96-well flat-bottom polysterene microtitre plate (Dynatech Micro-ELISA system, Germany). The remaining wells were coated with 50 III per well of BSA in CBCB. After overnight incubation at 37°C blocking was done with 1% BSA in PBST. Sera (I : 300 dilution) and eluates of blood (1 : 40 dilution) were added to both antigen and BSA coated wells in duplicate. After I hour incubation at 37°C peroxidase conjugated anti-human IgM (Dako, Denmark) at 1: 2000 dilution was added to all wells and incubated at 37°C for 1 hour. A substrate solution (0-phenylenediamine and H 2 0 2 ) in citrate buffer pH 5·0 was added. The reaction was stopped with 5 N H 2 S0 4 . The optical density was read at 492 nm in an ELISA reader (MR 600 microplate reader, Dynatec). The difference in OD values between the antigen and BSA coated wells was calculated for each sample. The mean value of duplicate wells was taken. A mean difference of more than 0·2 OD was considered positive.
The serodia-leprae microtitre particle agglutination test kit for detection of anti-PGL antibody was supplied as a gift by Fujirebio Inc., Japan. (The gelatin particles were sensitized with NT-P-BSA, a semi-synthetic antigen .) The lyophilized unsensitized and sensitized particles were reconstituted with a reconstitution solution supplied with the kit 30 minutes before starting the test.
PROCEDURE FOR THE MLPA WITH DIRECT SERA
A serum diluent of 75 /11 was added to the first well and 25 /11 of the diluent was added to the second and subsequent wells of a 96 U bottom microtitre plate, 25 /11 of test serum were added to the first well (I : 4 dilution). After mixing, 25 /11 of diluted serum from the first well were transferred to the second well (1 : 8 dilution) and this doubling dilution was carried out from the second well to the third well and so on. Unsensitized particles totalling 25 /11 were added to the second well only (1 : 16 dilution) and 25 /11 of sensitized particles were added to the third and subsequent wells (dilutions I: 32, I: 64 up to I: 512). The plates were covered and thoroughly mixed on a rotator at 160 cpm for I minute, and then incubated at 37°C in a moist chamber. The reading of the results was carried out visually. Agglutination with sensitized particles was read in comparison with unsensitized particles as negative, +, + +, + + +. The highest dilution at which the agglutination seen was taken as the end point titre for that sample. As suggested by the manufacturer, and also from our fu rther standardization, it was decided to use a titre of I : 64 as the cut off dilution for positivity for this test.
PROCEDURE FOR THE MLPA WITH ELUATES OF BLOOD
Serum diluent (30 /11) were added to the third well and subsequent wells, and 30 /11 of eluates (I : 20 dilution) were added to the first, second and third wells. From the third well after mixing, 30 /11 of diluted serum were transferred to the fo urth well and this doubling dilution was continued for subsequent wells.
Unsensitized particles totalling IS /11 were added to the first well only (1 : 30 dilution) and IS /11 of sensitized particles were added to the second, third and subsequent wells (I : 30, I : 60, 1: 120 up to I :480 dilution). The rest of the procedure was the same as for the test using direct sera. After standardization it was decided to have I : 60 as the cut-off dilution for this test.
Results
To establish the reproducibility of the MLPA test with eluates of blood, 81 samples were initially screened. The MLPA test was done with both eluates and direct sera. They belonged to 39 leprosy patients (LL-19, BL-6, TT-5, BT-4, PN-5), 9 pregnant women and 33 occupational contacts. We fo und an excellent positive correlation between the MLPA test done with eluates and direct sera. The concordance rate was fo und to be 97· 5% ( Table   I ). Reading the result as positive or negative in both methods was fo und to be easy. The MLPA test done with the sera showed a positivity in 76% (19/25) of MB cases, 79% (10/ 14) of PB cases and 3·03% (1/33) of occupational contacts, whereas the MLPA test done with eluates showed a positivity in 80% (20/25) of MB cases, 64% (9/ 14) of PB cases and 3·03% (1/33) of occupational contacts.
Using 217 samples, we compared MLPA with ELISA using eluates from blood spots on filter paper as described above ( Table 2 ). The samples comprised of 65 leprosy patients (LL-active 14, LL-inactive-14, BL active-7, BL inactive-7 TT-13, BT-5, PN-5), 49 household contacts, 61 noncontacts, 33 occupational contacts and 9 pregnant women. We fo und a good positive correlation between the results obtained with the ELISA and MLPA tests. The concordance rate was found to be 92·6% (ranging from 71·4% to 100%). ELISA showed a positivity in 83·3% (35/42) of MB cases, 65·2% (15/23) of PB cases, 6· 1 % (3/49) of household contacts, 9·8% (6/6 1) of non contacts and 3·03% (1/33) of occupational contacts. MLPA showed a positivity in 71-4% (30/42) of MB cases, 60·9% (14/23) of PB cases, 1·6% (1/61) of noncontacts and 3·03% (1/33) of occupational contacts. The efficiency of both these tests was fo und to be comparable (Table 3) . The MLPA positive samples had a mean ELISA value of 0·561 ± 0·314 (0· 175 to 1·131), while the MLPA negative samples had 0· 133 ±0·111 (0·00 to 0·53). Of the 217 samples, 16 samples showed a lack of concordance, 15 of which (6·9%) were only ELISA positive. They consisted of LL active-I, LL inactive-2, BL inactive-2, TT-2, HHC-3 NC-5. One sample (PN) was only positive by MLPA (0·5%) ( Table 2 ). The OD values by ELISA for these samples ranged from O· 20 to O' 53 (0' 309 ± 0' 1 25). All these sera were stored at -20°C between 2 and 10·5 months (7·6 ±2·5 months). The nonconcor dance was not observed when freshly collected samples were used for MLPA.
r----------------------------------------
Further the attempt to correlate the result of ELISA (expressed as OD) with the titre Agreement in reading the grade ( +, + +, + + + ) of the result = Kappa = 0048.
Kappa more than 0'75--excellent, Kappa between 0040 and 0·75-Fair to Good, Kappa below 0·4<J--poor agree ment I S of MLPA (expressed in dilution) revealed that there was no statistically significant correlation between these results ( Figure I , r = 0, 17).
When we analysed the interobserver variation in reading the MLPA result, it showed that the agreement for reading the result as positive or negative between the observers was excellent (Kappa = 0,88), whereas the agreement for reading the grade of the results ( +, + +, + + + ) between the observers was fo und to be fair to good (Kappa = 0,48). The variation was fo und to be in the range of I + (Table 4) .
Discussion
Since the development of anti-POL ELISA,I, 2 the serology of leprosy has changed a lot with the introduction of many synthetic glycoconjugates of POL-I.3-8 The antibody response to POL-T is predominantly JgM. The antibody level increases from TT to LL across the spectrum of leprosy. In recent years studies using ELISA have reported a significant proportion of subjects in endemic areas showing a high positive antibody response to POL antigen without any clinical signs of leprosy.1 2 ,13 Many studies have shown the possible use of anti-POL ELISA as a monitor for chemotherapy, as the antibody level was shown to be decreased by effective chemotherapy. [14] [15] [16] Recently a much simpler and less time consuming MLPA test was introduced.lo The comparative study of MLPA and ELISA for detection of IgM anti-POL antibody titre proved that both the methods basically have identical sensitivity and specificity. MLPA, however, cannot detect IgO antibody, because of the poor agglutination capacity of IgO anti-POL-I antibody. We proposed to compare these two methods and fu rther attempted to simplify the test by using samples from eluates of blood spots from filter paper. Anti POL-I ELISA using eluates from blood spots collected on filter paper is routinely done in our laboratory. It is fo und to be a suitable method fo r the large scale screening of samples, which was observed by other workers.17 Initially we compared the MLPA test using direct sera with the MLPA test using eluates of blood from filter paper. We fo und an excellent positive correlation between these two methods, with a concordance rate of97·5%. As the amount of antigen used is less, 50% more tests can be done with the same amount of the eluates of blood.
When we compared MLPA with ELISA using eluates from blood spots on filter paper, we fo und a very good positive correlation between these two methods. The concordance rate was fo und to be 92·6%. This is in agreement with the observations of other workers. lo Of the 217 samples, 16 showed nonconcordance (7·5%), of which 15 samples were positive by ELISA only. These samples showed 00 in ELISA, ranging from 0·20 to 0·53. All these sera were stored at -20°C between 2 and 10·5 months (7·6 ±2·5 months). This nonconcordance was not fo und when freshly collected samples were used for MLPA. The serological test with eluates should be done as soon as possible after collection, an important fact that was also observed by other workers. 17 Further we attempted to correlate the activity of ELISA with that of MLPA. It revealed that there was no statistically significant correlation between the results of these two methods (r =0.17). Although we used NO-O-BSA antigen in ELISA, the correlation with NT-P BSA in MLPA was good-this was observed by other workers,9 as was a good correlation between PGL-I and ND-O-BSA in latex agglutination tests. Resumen Se realizo una comparacion entre la prueba ELISA con la recien desarrollada prueba MLPA, utilizando eluatos de manchas de sangre en papel de filtro para la deteccion del anticuerpo anti-PGL-1. Se obtuvo una muy buena correlacion positiva entre las dos pruebas. EI coeficiente de concordancia obtenido fue 92,6%, con una escala de 71,4% a 100%. No se obtuvo esta falta de concordancia cuando se usaron muestras frescas. La prueba MLPA es sencilla y fiable. EI uso de eluatos de manchas de sangre en papel de filtro simplifica la prueba aun mas en cuestion de la recoleccion y el transporte de muestras de sangre. Este rapido y ex acto metodo hace que la prueba MLPA sea factible logisticamente para estudios en gran escala. Nuestra modificacion de la MLPA usando eluatos y el kit permite el estudio de mas muestras que usando sueros.
